Back to KA Kayne Anderson Rudnick Investment Management LLC
RYTM
Showing 0 of 2 quarters
Position history for KAKayne Anderson Rudnick Investment Management LLC's holdings in Rhythm Pharmaceuticals, Inc.
No. Kayne Anderson Rudnick Investment Management exited its RYTM (Rhythm Pharmaceuticals) position in Q2 2022. Its Q1 2022 13F listed 72 shares worth $1,000. Kayne Anderson Rudnick Investment Management first reported RYTM in Q1 2022 and held it in 1 quarterly 13F filing.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.